Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Play bike games, free online bike games online.
Popular Articles

Illinois Public Health Director Presents At H1N1 Flu Preparedness Summit To Further Prepare For Possibility Of More Severe H1N1 Outbreak In The Fall
Speaking at a national summit this week on H1N1 flu preparedness, Dr. Damon T. Arnold, state public health director, stressed the need to prepare for the possibility the fall flu season could be more severe than normal.
generic viagra online
Quality Of GP Consultations Drives High Patient Satisfaction, UK
Being given enough time with a GP and feeling that their problems are taken seriously are the most important factor in patients" satisfaction with their local surgery, according to new data out today. The GP Patient Survey, the biggest healthcare survey of its kind, found that overall satisfaction with surgeries was high at 91%, but there is still room for improvement in accessing GP services, especially getting through on the phone and being able to make appointments more than 48 hours in advance.
News of the day
Engineering Autism: Mice With Extra Chromosome Region Show Many Autistic Signs
Mice who inherit a particular chromosomal duplication from their fathers show many behaviors associated with human autism, researchers report in the June 26th issue of the journal Cell, a Cell Press Publication. The duplicated chromosomal region in mice is the equivalent of human chromosome 15q11-13, the most frequent cytogenetic abnormality observed in autism, accounting for some five percent of all cases.
Endocrinology

Significant Milestone Marks The Beginning Of FDA-Authorized Breast Cancer Trial

Quantum Immunologics, Inc. (QI), a Tampa, Florida company focusing on the research and development of cancer immunotherapies, announces that the first patient in its breast cancer trial has begun to receive its dendritic cell therapy. QI is currently sponsoring and conducting an FDA-authorized Phase I/II clinical trial testing the safety and efficacy of its immunotherapy on 27 Stage IV breast cancer patients who have failed conventional therapy. According to Mr. Chuck Broes, CEO of QI, "This achievement marks a significant milestone in the life cycle of our company, and we look forward with great hope and commitment as we aspire to a successful trial outcome." The clinical trials involve the use of dendritic cell therapy using the oncofetal antigen ("OFA"), or iLRP -- immature Laminin Receptor Protein, as a cancer antigen (a protein found on cancer cells that can be targeted by the body"s own immune system) found in many tumor cell lines or fetal tissue, but absent on normal, healthy tissue. QI believes that the OFA antigen can serve as a unique, valuable and promising antigen for individualized breast cancer immunotherapy. Centered in Mobile, AL, QI"s clinical trial is designed around the use of QI"s proprietary dendritic cell therapy, which employs OFA to recruit the patient"s own immune system to target and attack the cancer cells with the intent to improve patient survivability and quality of life. Each patient will receive three monthly injections of the patient"s own dendritic cells that have been sensitized to OFA. It is anticipated that once the sensitized cells are injected back into the patient, the patient"s T-cells will locate the OFA found on the patient"s cancer cells, thereby generating an immune response with the goal of killing the cancer cells and preventing further spread of the disease. About Quantum Immunologics Quantum Immunologics, Inc. ("QI") is a research-driven biotechnology company that is pioneering discoveries in immunotherapy science. QI is dedicated to the research, development and production of technologies that focus on the treatments and diagnoses of cancer and other diseases related to the immune system. Leveraging an expansive pipeline of biopharmaceutical innovations, QI remains committed to advancing medicine with the ultimate goal of dramatically improving lives. Quantum Immunologics, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009